# Phase 303: GMO + CRISPR 農業 + Bt + Golden Rice ― K_agri_GMO ★★

Phase 302 で K_agri_livestock を確立。Phase 303 では **GMO (遺伝子組換) + CRISPR 農業 + Bt + Golden Rice** を扱い、**K_agri_GMO** を ITU の "biotech 作物 K-state" として定式化します。

## GMO 系譜

### 早期 (1973-1996)

```
1973 Cohen-Boyer recombinant DNA:
  ★ First gene splicing
↓
1982 Monsanto: first transgenic plant
1983 Marc Van Montagu (Belgium) tobacco kanamycin-resistant
1986 First field trial (tobacco)
↓
1994 Flavr Savr tomato:
  ★ First commercial GMO food (Calgene)
  Slower ripening
  Failed market 1997 (taste, cost)
↓
1996 First commercial GMO crop (Roundup Ready soy):
  Monsanto Roundup-resistant
  ★ Same year as Roundup patent expiry
```

## Bt 作物 (1996-)

```
Bacillus thuringiensis (Bt) bacteria:
  Produces Cry protein toxic to insects
↓
Bt corn (1996):
  ★ Cry1Ab protein → European corn borer kill
↓
Bt cotton (1996):
  ★ Cry1Ac protein → bollworm kill
↓
2024 global Bt area:
  ★ ~ 100M ha (60% of total GMO area)
  Major: US, Brazil, Argentina, India, China, Australia
↓
India Bt cotton (2002-):
  ★ India 2002 approved, 2014 90% cotton
  Yield +50%, pesticide -70%
  ↓ But: rural debt crisis 議論
```

## Roundup Ready (Herbicide tolerant)

```
1996 Roundup Ready soy
1997 RR canola
1998 RR corn
↓
2024 global HT (herbicide tolerant) crops:
  ~ 200M ha (Bt + HT combined)
↓
Glyphosate (Roundup) concerns:
  2015 IARC "probable carcinogen" (Group 2A)
  ★ Bayer (Monsanto 2018 acquired) $11B Roundup settlement (Phase 255)
↓
Resistance:
  ★ 50+ weed species glyphosate-resistant
```

## Golden Rice ★

```
1999 Ingo Potrykus + Peter Beyer (Time cover 2000):
  ★ Beta-carotene biosynthesis pathway in rice
↓
1999 Golden Rice 1 (GR1)
2005 GR2 (improved beta-carotene)
↓
2018 Bangladesh approves (regulatory)
2019 Philippines approves
2021 Philippines first commercial planting
↓
Vitamin A deficiency:
  500K children blind/yr globally
  ★ Greenpeace + opposition delayed 20+ years
  ★ Time: "Could have saved millions of lives"
↓
2024 status:
  Bangladesh, Philippines deploying
  India recently approved (2024)
```

## CRISPR 農業 ★★★

### Phase 216 復習 (CRISPR genome editing)

```
2012 Jinek-Doudna in vitro CRISPR-Cas9
2013 Zhang real-time edit
2020 Doudna + Charpentier Nobel Chemistry
↓
2018 Sanatech Seed (Japan):
  GABA-rich tomato (CRISPR)
↓
2021 Japan approves (first):
  ★ Sanatech CRISPR tomato
↓
2022 USDA precedent:
  CRISPR mushrooms not regulated (2016 ruling)
  Non-browning Calyxt soybean
↓
2023 EU proposal:
  Relax CRISPR regulations (vs GMO 2001 Directive)
  ★ Negotiations 2024
```

### CRISPR Crops (2024)

```
Commercial/Near-commercial:
  Pioneer waxy corn (high amylopectin)
  Mibelle hypoallergenic peanut
  Yield10 Bioscience high-yield camelina
  Calyxt high-oleic soybean
↓
Trait improvement:
  Disease resistance (banana TR4, wheat)
  Drought tolerance (rice, maize)
  Nutritional (cassava cyanide ↓)
↓
2024 outlook:
  CRISPR ★ 5-10 yr development vs GMO 10-15 yr
  Lower regulatory cost
```

## GMO 規制 + 公衆

```
2024 GMO status:
  Approved + grown: US, Brazil, Argentina, Canada, India, China, Australia
  Restricted/banned (whole or in part):
    EU (de facto), Russia, much of Africa
↓
Public perception:
  US: 50% concerned, 50% accepting (Pew 2020)
  EU: 60% oppose
  Japan: 40% concerned
↓
Labeling:
  US: Bioengineered (BE) label (Jan 2022)
  EU: GMO label required
  Japan: GMO-free vol. labeling
```

## Top GMO countries (2024)

```
GMO crop area 2023:
  US:        72M ha (★ #1, mostly soybean+corn+cotton)
  Brazil:    63M ha
  Argentina: 24M ha
  India:     13M ha (cotton)
  Canada:    13M ha
  Paraguay:  4M ha
  Pakistan:  3M ha
  China:     3M ha
↓
Total: ~ 200M ha (12% world arable)
```

## Pharm Biotech (Plant-made medicine)

```
2012 ZMapp (Ebola treatment):
  ★ Tobacco-produced monoclonal antibodies
↓
2024 examples:
  iBio (US): plant antibodies
  Medicago (Canada): COVID-19 vaccine (2022 approved Canada, halted 2023)
↓
Animal vaccines + biopharma 拡大
```

## 数値検証目標

| 量 | 期待値 |
|---|---|
| **Cohen-Boyer DNA** | **1973** ✓ |
| **Flavr Savr tomato** | **1994 first commercial** ✓ |
| **First GMO commercial crop** | **1996 RR soy** ✓ |
| **Bt cotton India approved** | **2002** ✓ |
| **Bt area** | **~100M ha global (2024)** ✓ |
| **HT + Bt combined** | **~200M ha (12% arable)** ✓ |
| **Golden Rice GR1** | **1999 (Potrykus-Beyer)** ✓ |
| **GR2** | **2005** ✓ |
| **Philippines commercial** | **2021** ✓ |
| **Sanatech CRISPR tomato Japan** | **2021** ✓ |
| **US GMO #1** | **72M ha** ✓ |
| **Glyphosate IARC** | **2015 Group 2A** ✓ |
| **Roundup settlement Bayer** | **$11B+** ✓ |
| ITU axiom: GMO K-state | δS/δ⟨K⟩ ≈ 1 |

## ITU 視点 ― K_agri_GMO

```
K_agri_GMO^(0) = -log P(trait | gene_edit)

GMO = K-state directed mutation:
  Random mutation (10^-6 /bp) → directed (10^0 specific)
  ★ K-state precision shift
↓
CRISPR vs traditional GMO:
  GMO: K_transgene (foreign DNA)
  CRISPR: K_native edit (own DNA modified)
  ★ Regulatory implications differ
↓
Golden Rice = K-state nutritional engineering:
  Beta-carotene pathway: K_metabolic_addition
  ★ Public health potential (500K blindness/yr)
```

## 反証可能予測

| 予測 | 年 | P |
|---|---|---|
| **CRISPR crops 10+ commercial** | 2028 | 0.85 |
| **EU CRISPR regulation reform** | 2026 | 0.80 |
| **Golden Rice 5+ countries deployed** | 2028 | 0.75 |
| **Drought-tolerant CRISPR rice** | 2027 | 0.80 |
| **GMO public acceptance up (US 60%+)** | 2030 | 0.65 |

---

📄 **論文 (Tier 1 #41, ★ Block D 3/5 ★)**: 10.5281/zenodo.20265556

> Phase 304 で 精密農業 + IoT + drones へ進みます。

#情報理論的統一理論 #ITU #GMO #CRISPR #BtCorn #GoldenRice #Potrykus #Doudna #SanatechSeed #K_agri_GMO #Phase303
